首页 | 本学科首页   官方微博 | 高级检索  
     


Amodiaquine improves insulin resistance and lipid metabolism in diabetic model mice
Authors:Hoe‐Yune Jung PhD  Bobae Kim MS  Hye Guk Ryu MS  Yosep Ji PhD  Soyoung Park PhD  Seung Hee Choi PhD  Dohyun Lee PhD  In‐Kyu Lee MD  Munki Kim PhD  You Jeong Lee MD  Woojin Song PhD  Young Hee Lee BS  Hyung Jin Choi MD  Chang‐Kee Hyun PhD  Wilhelm H Holzapfel PhD  Kyong‐Tai Kim PhD
Affiliation:1. Department of Integrative Biosciences and Biotechnology, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea;2. R&D Center, NovMetaPharma Co., Ltd., Pohang, Republic of Korea;3. Department of Advanced Green Energy and Environment, Handong Global University, Pohang, Republic of Korea;4. School of Life Science, Handong Global University, Pohang, Republic of Korea;5. Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea;6. Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of Korea;7. Department of Internal Medicine, Kyungpook National University School of Medicine, Daegu, Republic of Korea;8. Leading‐Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, Republic of Korea;9. Bio Convergence Team, Advanced Bio Convergence Center, Pohang, Republic of Korea;10. Academy of Immunology and Microbiology, Institute for Basic Science (IBS), Pohang, Republic of Korea;11. Functional Neuroanatomy of Metabolism Regulation Laboratory, Department of Anatomy, Division of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
Abstract:
Keywords:antidiabetic drug  dyslipidaemia  fatty liver  glycaemic control  glucose metabolism  insulin resistance
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号